Insights

Dr Barnes reviews key abstracts from ECCO 2023 on novel therapeutics for inflammatory bowel disease with hosts Drs Raymond Cross and Millie Long.

At the April 30 virtual regional meeting of Advances in Inflammatory Bowel Diseases, Dr Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center, discussed key steps gastroenterologists can take to help ensure their patients...

In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk to Dr Sara Horst about abstracts from the ECCO ’23 Congress on how best to utilize ozanimod to achieve optimum outcomes in inflammatory bowel disease.

Dr Cleveland, from the University of Chicago, reviews the use of intestinal ultrasound for the monitoring of inflammatory bowel disease and the significant advantages of this noninvasive, point-of-care technology for patients and clinicians...

S1Ps may work best for patients with moderate to more moderate-severe range of ulcerative colitis in the outpatient setting, particularly those earlier in their treatment journey, Dr Raymond Cross said during his presentation at the AIBD...

When used correctly and in a timely manner, biosimilars may increase access to important medications, such as the anti-tumor necrosis factor inhibitors for the treatment of IBD, Christina Ha, MD, explained at the AIBD regional meeting.

Drs Wallach and Rosenbaum discuss their study into the trends of IBD incidence among children in New York City during the COVID-19 pandemic, and their surprising findings.

Dr Adam Faye elaborates on how antibiotic exposure puts adults aged 40 years and older at an increased risk for developing inflammatory bowel disease.

In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk with Dr Peter Higgins from the University of Michigan about the etiology of inflammatory bowel disease, including what is and what is not known, the hygiene hypothesis,...